Ballard TM

References (3)

Title : Drug targets for cognitive enhancement in neuropsychiatric disorders - Wallace_2011_Pharmacol.Biochem.Behav_99_130
Author(s) : Wallace TL , Ballard TM , Pouzet B , Riedel WJ , Wettstein JG
Ref : Pharmacol Biochem Behav , 99 :130 , 2011
Abstract : Wallace_2011_Pharmacol.Biochem.Behav_99_130
ESTHER : Wallace_2011_Pharmacol.Biochem.Behav_99_130
PubMedSearch : Wallace_2011_Pharmacol.Biochem.Behav_99_130
PubMedID: 21463652

Title : Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2\/3 antagonists - Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
Author(s) : Woltering TJ , Wichmann J , Goetschi E , Knoflach F , Ballard TM , Huwyler J , Gatti S
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :6969 , 2010
Abstract : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
ESTHER : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
PubMedSearch : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
PubMedID: 20971004

Title : The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats - Ballard_1999_Psychopharmacology_146_10
Author(s) : Ballard TM , McAllister KH
Ref : Psychopharmacology , 146 :10 , 1999
Abstract : Ballard_1999_Psychopharmacology_146_10
ESTHER : Ballard_1999_Psychopharmacology_146_10
PubMedSearch : Ballard_1999_Psychopharmacology_146_10
PubMedID: 10485959